Not Yet RecruitingPhase 3ACTRN12607000389404

Efficacy of ultrasound guided Transversus Abdominis Plane (TAP) block following major abdominal surgery: a randomised controlled trial.

women undergo elective caesarean section-Transversus Abdominis Plane (TAP) block on the abdominal wall under ultrasound guidance-conventional postoperative analgesic management-reduce pain medications post operation and improve patient comfort

Sponsor

Department of Anaesthesia, St Vincent's Hospital

Enrollment

104 participants

Start Date

Jul 21, 2007

Study Type

Interventional

Conditions

healthy women undergo elective caesarean section, no allergy to the analgesic drug ropivacaine and morphine.

Summary

The object of this project is to determine how useful an ultrasound guided TAP block is in reducing requirement for pain medications following elective caesarean section.

Eligibility

Sex: FemalesMin Age: 18 Yearss

Plain Language Summary

Simplified for easier understanding

This study investigates Efficacy of ultrasound guided Transversus Abdominis Plane (TAP) block following major abdominal surgery: a randomised controlled trial. It is open to women only, aged 18 and older. If you are interested, you may need to attend study visits and follow the research team's instructions.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Intervention: patient receive ropivacaine 200mg by the TAP block technique. All patients will be treated with standardised pain management and post analgesic care after surgery including a Patient Co

Intervention: patient receive ropivacaine 200mg by the TAP block technique. All patients will be treated with standardised pain management and post analgesic care after surgery including a Patient Controlled Analgesia (PCA) device which will deliver standard doses of morphine (1mg with a 5 minute lockout) intravenously when patient requires it for pain relief.

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12607000389404